The treatment by E2 of HA22T HCC cells results in enhanced binding of ERα to β-catenin, triggers the binding of β-catenin and β-TrCP, and promotes the degradation of β-catenin, leading to the inhibition of the migration and invasion of HA22T cells [181]. This evidence concerns the gene BTRC and hepatocellular carcinoma.